Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.96 is 86% below its 5-year average of 14.44, near the low end of its 5-year range (1.87–42.75).
As of the fiscal period ended Tuesday, June 30, 2026. 25.19% below its 12-month average of 2.62.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.96.
QUICK RATIO (ACID-TEST)
1.96
QUICK RATIO (ACID-TEST) AVG TTM
2.62
QUICK RATIO (ACID-TEST) AVG 3Y
6.90
QUICK RATIO (ACID-TEST) AVG 5Y
14.44
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-25.19%
CURRENT VS 3Y AVG
-71.65%
CURRENT VS 5Y AVG
-86.45%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.32
median of 859 covered companies
CURRENT VS SECTOR MEDIAN
-41.06%
vs the sector median at left
Lantern Pharma Inc.
Market Cap
$12.31M
Quick Ratio (Acid-Test)
1.96
TTM Avg
2.62
3Y Avg
6.90
5Y Avg
14.44
Market Cap
$12.19M
Quick Ratio (Acid-Test)
1.08
TTM Avg
1.32
3Y Avg
1.15
5Y Avg
1.64
Market Cap
$12.54M
Quick Ratio (Acid-Test)
0.38
TTM Avg
2.35
3Y Avg
3.38
5Y Avg
3.85
Market Cap
$12.54M
Quick Ratio (Acid-Test)
6.66
TTM Avg
2.77
3Y Avg
1.93
5Y Avg
5.53
Market Cap
$12.51M
Quick Ratio (Acid-Test)
0.99
TTM Avg
0.99
3Y Avg
1.05
5Y Avg
1.43
Market Cap
$12.66M
Quick Ratio (Acid-Test)
0.50
TTM Avg
1.75
3Y Avg
2.03
5Y Avg
3.39
Market Cap
$12.71M
Quick Ratio (Acid-Test)
10.57
TTM Avg
6.64
3Y Avg
7.08
5Y Avg
4.73
Market Cap
$12.95M
Quick Ratio (Acid-Test)
1.22
TTM Avg
3.07
3Y Avg
6.03
5Y Avg
8.35
Market Cap
$11.56M
Quick Ratio (Acid-Test)
15.87
TTM Avg
27.51
3Y Avg
16.79
5Y Avg
13.69
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lantern Pharma Inc. (LTRN) | $12.31M | 1.96 | 2.62 | 6.90 | 14.44 |
| IRIDEX Corporation (IRIX)vs › | $12.19M | 1.08 | 1.32 | 1.15 | 1.64 |
| Tempest Therapeutics, Inc. (TPST)vs › | $12.54M | 0.38 | 2.35 | 3.38 | 3.85 |
| Cellectar Biosciences, Inc. (CLRB)vs › | $12.54M | 6.66 | 2.77 | 1.93 | 5.53 |
| Dare Bioscience, Inc. (DARE)vs › | $12.51M | 0.99 | 0.99 | 1.05 | 1.43 |
| Cytosorbents Corporation (CTSO)vs › | $12.66M | 0.50 | 1.75 | 2.03 | 3.39 |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $12.71M | 10.57 | 6.64 | 7.08 | 4.73 |
| Passage Bio, Inc. (PASG)vs › | $12.95M | 1.22 | 3.07 | 6.03 | 8.35 |
| Phio Pharmaceuticals Corp. (PHIO)vs › | $11.56M | 15.87 | 27.51 | 16.79 | 13.69 |
| IN8bio, Inc. (INAB)vs › | $13.23M | 8.21 | 6.45 | 5.32 | 7.60 |
Quick Ratio
1.96
Excludes inventory
Current Ratio
1.96
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.96 |
| 2026-03-31 | 1.87 |
| 2025-12-31 | 2.40 |
| 2025-09-30 | 3.33 |
| 2025-06-30 | 3.52 |
| 2025-03-31 | 4.86 |
| 2024-12-31 | 5.83 |
| 2024-09-30 | 8.31 |
| 2024-06-30 | 7.67 |
| 2024-03-31 | 9.98 |
| 2023-12-31 | 16.18 |
| 2023-09-30 | 21.05 |
| 2023-06-30 | 16.92 |
| 2023-03-31 | 19.75 |
| 2022-12-31 | 20.99 |
| 2022-09-30 | 19.76 |
| 2022-06-30 | 12.38 |
| 2022-03-31 | 22.01 |
| 2021-12-31 | 31.26 |
| 2021-09-30 | 42.75 |
| 2021-06-30 | 30.55 |
| 2021-03-31 | 124.12 |
| 2020-12-31 | 36.64 |
| 2020-09-30 | 27.59 |
| 2020-06-30 | 11.24 |
| 2020-03-31 | 1.53 |
| 2019-12-31 | 2.52 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
